Pyridoxine-Responsive Seizures in Infantile Hypophosphatasia and a Novel Homozygous Mutation in ALPL Gene
Authors:
Open Access
- 1 September 2016
- journal article
- case report
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 8 (3) , 360-364
Abstract
Hypophosphatasia is a rare inherited disorder of bone and mineral metabolism caused by a number of loss-of-function mutations in the ALPL gene. It is characterized by defective bone and tooth mineralisation associated with low serum and bone alkaline phosphatase activity. The clinical presentation of this disease is extremely variable. For this reason, the diagnosis can be difficult and is often missed out or delayed. Hypophosphatasia is classified into subtypes based on the age of onset and clinical features. The clinical severity is associated with the age at diagnosis and the lack of tissue-nonspecific alkaline phosphatase activity; the severe forms of hypophosphatasia are primarily perinatal and infantile forms. Severe forms may present with many neurological problems such as seizures, hypotonia, irritability. Herein, we report the case of an infantile hypophosphatasia patient who presented with pyridoxine-responsive seizures and a novel homozygous mutation in the ALPL gene was detected. There is a limited number of hypophosphatasia patients with pyridoxine-responsive seizures in the literature, so early diagnosis of infantile hypophosphatasia in the clinically compatible patients allows more effective postnatal care/management and genetic counseling for further pregnancies.Keywords
This publication has 16 references indexed in Scilit:
- Hypophosphatasia: an overview of the disease and its treatmentOsteoporosis International, 2015
- Clinical, pathological and genetic evaluations of Chinese patients with autosomal-dominant hypophosphatasiaArchives of Oral Biology, 2010
- Physiological role of alkaline phosphatase explored in hypophosphatasiaAnnals of the New York Academy of Sciences, 2010
- Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.1112C>T, p.T371I) of the tissue-nonspecific alkaline phosphatase geneBone, 2007
- Childhood Hypophosphatasia Due to a de Novo Missense Mutation in the Tissue-Nonspecific Alkaline Phosphatase GeneThe Journal of Clinical Endocrinology & Metabolism, 2005
- Severe hypophosphatasia: Characterization of fifteen novel mutations in the ALPL geneHuman Mutation, 2003
- Pyridoxine-Dependent Seizures Associated With Hypophosphatasia in a NewbornJournal of Child Neurology, 2002
- Glu274Lys/Gly309Arg Mutation of the Tissue‐Nonspecific Alkaline Phosphatase Gene in Neonatal Hypophosphatasia Associated with ConvulsionsJournal of Inherited Metabolic Disease, 2002
- Perinatal hypophosphatasia: radiology, pathology and molecular biology studies in a family harboring a splicing mutation (648+1A) and a novel missense mutation (N400S) in the tissue-nonspecific alkaline phosphatase (TNSALP) gene.2001
- "HYPOPHOSPHATASIA"A.M.A. American Journal of Diseases of Children, 1948